year 16, Issue 4 (July - August 2022)                   Iran J Med Microbiol 2022, 16(4): 312-323 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Majdani R, Hatefirad R. Isolation and Characterization of Two Lytic Bacteriophages Against Pseudomonas aeruginosa and Evaluation of Their Antibacterial Effects on Clinical Isolates of Staphylococcus aureus and Escherichia coli in The Northwest of Iran. Iran J Med Microbiol. 2022; 16 (4) :312-323
URL: http://ijmm.ir/article-1-1324-en.html
1- Department of Biology, Faculty of Basic Sciences, University of Maragheh, Maragheh, Iran , rahelehmajdani@yahoo.com
2- Department of Biology, Faculty of Basic Sciences, University of Maragheh, Maragheh, Iran
Abstract:   (730 Views)

Background and Objective: This study was carried out to isolate lytic bacteriophages against Pseudomonas aeruginosa and analyze their biological characteristics and antibacterial effects on other clinical isolates of bacteria.
Methods: Isolating two lytic bacteriophages against two strains of P. aeruginosa was carried out using the double-layer agar method. After investigating the antibacterial potential of the phages, the morphology of both phages was studied. The absorption rate and one-step growth curve of each phage were also determined. The survival rate of isolated phages was evaluated against different physical conditions, chemicals, and organic solvents. Then, the antibacterial potential of phages against clinical multidrug-resistant isolates of P. aeruginosa, Staphylococcus aureus, Escherichia coli, and Klebsiella pneuminiae, as well as standard strains of P. aeruginosa ATCC 27853, P. aeruginosa ATCC 9027, K. pneumonia ATCC 1290, S. aureus ATCC 25923, and Salmonella enterica ATCC 19430 and E. coli ATCC 8739, was determined.
Results: One of the phages showed antibacterial effects on 50% of P. aeruginosa. Both phages had a high absorption rate, short latent period, and high burst size. Isolated bacteriophages belonged to the Cystoviridae family, and the highest stability of phages (PPaMa3/19 and PPaMa4/19) was observed at pH= 7 and a temperature of 4°C. The organic solvents and ionic detergents used in this study decreased the titers of both phages. Also, the highest anti-phage activity belonged to ethanol and acetone. PPaMa4/19 phage, unlike PPaMa3/19, was also lethal against E. coli (40%) and S. aureus (20%) bacteria.
Conclusion: Phage PPaMa4/19 had high antibacterial potential against P. aeruginosa, S. aureus, and E. coli bacteria. What's more, it can be used for therapeutic purposes after more analysis. It is essential to consider the biological characteristics of phage stability and its resistance to infection treatment.

Full-Text [PDF 634 kb]   (200 Downloads) |   |   Full-Text (HTML)  (131 Views)  
Type of Study: Original Research Article | Subject: Microbial Genetics
Received: 2021/04/27 | Accepted: 2022/02/9 | ePublished: 2022/05/25

References
1. Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2000;2(9):1051-60. [DOI:10.1016/S1286-4579(00)01259-4]
2. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29(11):996-1011. [DOI:10.1086/591861] [PMID]
3. O'Flynn G, Ross RP, Fitzgerald GF, Coffey A. Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7. Appl Environ Microbiol. 2004;70(6):3417-24. [DOI:10.1128/AEM.70.6.3417-3424.2004] [PMID] [PMCID]
4. Gill JJ, Hyman P. Phage choice, isolation, and preparation for phage therapy. Curr Pharm Biotechnol. 2010;11(1):2-14. [DOI:10.2174/138920110790725311] [PMID]
5. Jamal M, Andleeb S, Jalil F, Imran M, Nawaz MA, Hussain T, et al. Isolation and characterization of a bacteriophage and its utilization against multi-drug resistant Pseudomonas aeruginosa-2995. Life Sci. 2017;190:21-8. [DOI:10.1016/j.lfs.2017.09.034] [PMID]
6. Abedon ST, Garcia P, Mullany P, Aminov R. Editorial: Phage Therapy: Past, Present and Future. Front Microbiol. 2017;8(8):981. [DOI:10.3389/fmicb.2017.00981] [PMID] [PMCID]
7. Kusuma SAF, Rostinawati T, Hendriani R, Budiman MF, Parwati I. Effect of water reservoirs types on the prevalence and antibiotic resistance profiles of Pseudomonas aeruginosa isolated from bathroom water in hospitals. J Adv Pharm Technol Res. 2021;12(1):52-6. [DOI:10.4103/japtr.JAPTR_103_20] [PMID] [PMCID]
8. Karamoddini MK, Fazli-Bazzaz BS, Emamipour F, Ghannad MS, Jahanshahi AR, Saed N, et al. Antibacterial efficacy of lytic bacteriophages against antibiotic-resistant Klebsiella species. ScientificWorldJournal. 2011;11:1332-40. [DOI:10.1100/tsw.2011.114] [PMID] [PMCID]
9. Jun JW, Kim JH, Shin SP, Han JE, Chai JY, Park SC. Characterization and complete genome sequence of the Shigella bacteriophage pSf-1. Res Microbiol. 2013;164(10):979-86. [DOI:10.1016/j.resmic.2013.08.007] [PMID]
10. Adams M. Methods of study of bacterial viruses. Bacteriophages. New York: Interscience publishers, Inc; 1959.
11. Wang Z, Zheng P, Ji W, Fu Q, Wang H, Yan Y, et al. SLPW: A Virulent Bacteriophage Targeting Methicillin-Resistant Staphylococcus aureus In vitro and In vivo. Front Microbiol. 2016;7:934. [DOI:10.3389/fmicb.2016.00934] [PMID] [PMCID]
12. Topka G, Bloch S, Nejman-Falenczyk B, Gasior T, Jurczak-Kurek A, Necel A, et al. Characterization of Bacteriophage vB-EcoS-95, Isolated From Urban Sewage and Revealing Extremely Rapid Lytic Development. Front Microbiol. 2018;9:3326. [DOI:10.3389/fmicb.2018.03326] [PMID] [PMCID]
13. Shende RK, Hirpurkar SD, Sannat C, Rawat N, Pandey V. Isolation and characterization of bacteriophages with lytic activity against common bacterial pathogens. Vet World. 2017;10(8):973-8. [DOI:10.14202/vetworld.2017.973-978] [PMID] [PMCID]
14. Jamal M, Chaudhry WN, Hussain T, Das CR, Andleeb S. Characterization of new Myoviridae bacteriophage WZ1 against multi-drug resistant (MDR) Shigella dysenteriae. J Basic Microbiol. 2015;55(4):420-31. [DOI:10.1002/jobm.201400688] [PMID]
15. Litt PK, Jaroni D. Isolation and Physiomorphological Characterization of Escherichia coli O157:H7-Infecting Bacteriophages Recovered from Beef Cattle Operations. Int J Microbiol. 2017;2017:7013236. [DOI:10.1155/2017/7013236] [PMID] [PMCID]
16. Litt PK, Saha J, Jaroni D. Characterization of Bacteriophages Targeting Non-O157 Shiga Toxigenic Escherichia coli. J Food Prot. 2018;81(5):785-94. [DOI:10.4315/0362-028X.JFP-17-460] [PMID]
17. Allue-Guardia A, Jofre J, Muniesa M. Stability and infectivity of cytolethal distending toxin type V gene-carrying bacteriophages in a water mesocosm and under different inactivation conditions. Appl Environ Microbiol. 2012;78(16):5818-23. [DOI:10.1128/AEM.00997-12] [PMID] [PMCID]
18. Jurczak-Kurek A, Gasior T, Nejman-Falenczyk B, Bloch S, Dydecka A, Topka G, et al. Biodiversity of bacteriophages: morphological and biological properties of a large group of phages isolated from urban sewage. Sci Rep. 2016;6(1):34338. [DOI:10.1038/srep34338] [PMID] [PMCID]
19. Jin J, Li Z-J, Wang S-W, Wang S-M, Huang D-H, Li Y-H, et al. Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates. BMC Microbiol. 2012;12(1):1-8. [DOI:10.1186/1471-2180-12-156] [PMID] [PMCID]
20. Parada V, Herndl GJ, Weinbauer MG. Viral burst size of heterotrophic prokaryotes in aquatic systems. J Mar Biolog Assoc. 2006;86(3):613-21. [DOI:10.1017/S002531540601352X]
21. Yamaki S, Omachi T, Kawai Y, Yamazaki K. Characterization of a novel Morganella morganii bacteriophage FSP1 isolated from river water. FEMS Microbiol Lett. 2014;359(2):166-72. [DOI:10.1111/1574-6968.12560] [PMID]
22. Yang X, Haque A, Matsuzaki S, Matsumoto T, Nakamura S. The Efficacy of Phage Therapy in a Murine Model of Pseudomonas aeruginosa Pneumonia and Sepsis. Front Microbiol. 2021;12:682255. [DOI:10.3389/fmicb.2021.682255] [PMID] [PMCID]
23. Forti F, Roach DR, Cafora M, Pasini ME, Horner DS, Fiscarelli EV, et al. Design of a broad-range bacteriophage cocktail that reduces Pseudomonas aeruginosa biofilms and treats acute infections in two animal models. Antimicrob Agents Chemother. 2018;62(6):e02573-17. [DOI:10.1128/AAC.02573-17] [PMID] [PMCID]
24. Shokri D, SOLEIMANIDELFAN A, Moayednia R, Mobasherizadeh S, SHIRSALIMIAN M, Enayatollahi S, et al. Isolation Identification and Evaluation of Two Lytic Bacteriophages Against Clinical Antibiotic-Resistant Strains of Pseudomonas aeruginosa from Waste Water and Hospital Sewage of Isfahan City. 2016.
25. Yang Y, Lu S, Shen W, Zhao X, Shen M, Tan Y, et al. Characterization of the first double-stranded RNA bacteriophage infecting Pseudomonas aeruginosa. Sci Rep. 2016;6(1):38795. [DOI:10.1038/srep38795] [PMID] [PMCID]
26. Jeon J, Yong D. Two Novel Bacteriophages Improve Survival in Galleria mellonella Infection and Mouse Acute Pneumonia Models Infected with Extensively Drug-Resistant Pseudomonas aeruginosa. Appl Environ Microbiol. 2019;85(9):e02900-18. [DOI:10.1128/AEM.02900-18] [PMID] [PMCID]
27. Adnan M, Ali Shah MR, Jamal M, Jalil F, Andleeb S, Nawaz MA, et al. Isolation and characterization of bacteriophage to control multidrug-resistant Pseudomonas aeruginosa planktonic cells and biofilm. Biologicals. 2020;63:89-96. [DOI:10.1016/j.biologicals.2019.10.003] [PMID]
28. Feng YY, Ong SL, Hu JY, Tan XL, Ng WJ. Effects of pH and temperature on the survival of coliphages MS2 and Qbeta. J Ind Microbiol Biotechnol. 2003;30(9):549-52. [DOI:10.1007/s10295-003-0080-y] [PMID]
29. Strack HB, Freese EB, Freese E. Comparison of mutation and inactivation rates induces by bacteriophage and transforming DNA by various mutagenes. Mutat Res - Fundam Mol Mech. 1964;1(1):10-21. [DOI:10.1016/0027-5107(64)90048-X]
30. Guo Y, Chen P, Lin Z, Wang T. Characterization of Two Pseudomonas aeruginosa Viruses vB_PaeM_SCUT-S1 and vB_PaeM_SCUT-S2. Viruses. 2019;11(4):318. [DOI:10.3390/v11040318] [PMID] [PMCID]
31. Ramirez K, Cazarez-Montoya C, Lopez-Moreno HS, Castro-Del Campo N. Bacteriophage cocktail for biocontrol of Escherichia coli O157:H7: Stability and potential allergenicity study. PLoS One. 2018;13(5):e0195023. [DOI:10.1371/journal.pone.0195023] [PMID] [PMCID]
32. YAMASHITA M, MURAHASHI H, TOMITA T, HIRATA A. Effect of Alcohols on Escherichia coil Phages. Biocontrol Science. 2000;5(1):9-16. [DOI:10.4265/bio.5.9]
33. Knezevic P, Kostanjsek R, Obreht D, Petrovic O. Isolation of Pseudomonas aeruginosa specific phages with broad activity spectra. Curr Microbiol. 2009;59(2):173-80. [DOI:10.1007/s00284-009-9417-8] [PMID]
34. de Melo ACC, da Mata Gomes A, Melo FL, Ardisson-Araujo DMP, de Vargas APC, Ely VL, et al. Characterization of a bacteriophage with broad host range against strains of Pseudomonas aeruginosa isolated from domestic animals. BMC Microbiol. 2019;19(1):134. [DOI:10.1186/s12866-019-1481-z] [PMID] [PMCID]
35. Cao Z, Zhang J, Niu YD, Cui N, Ma Y, Cao F, et al. Isolation and characterization of a "phiKMV-like" bacteriophage and its therapeutic effect on mink hemorrhagic pneumonia. PLoS One. 2015;10(1):e0116571. [DOI:10.1371/journal.pone.0116571] [PMID] [PMCID]
36. Sepulveda-Robles O, Kameyama L, Guarneros G. High diversity and novel species of Pseudomonas aeruginosa bacteriophages. Appl Environ Microbiol. 2012;78(12):4510-5. [DOI:10.1128/AEM.00065-12] [PMID] [PMCID]
37. Yang Y, Shen W, Zhong Q, Chen Q, He X, Baker JL, et al. Development of a Bacteriophage Cocktail to Constrain the Emergence of Phage-Resistant Pseudomonas aeruginosa. Front Microbiol. 2020;11:327. [DOI:10.3389/fmicb.2020.00327] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc